Latest Insider Transactions at Neurocrine Biosciences Inc (NBIX)
This section provides a real-time view of insider transactions for Neurocrine Biosciences Inc (NBIX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of NEUROCRINE BIOSCIENCES INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of NEUROCRINE BIOSCIENCES INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 07
2023
|
David W. Boyer Chief Corp. Affairs Officer |
SELL
Open market or private sale
|
Direct |
24,298
-59.31%
|
$2,478,396
$102.42 P/Share
|
|
Feb 07
2023
|
Matt Abernethy Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
26,328
-22.04%
|
$2,685,456
$102.38 P/Share
|
|
Feb 07
2023
|
Eric Benevich Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
17,390
-20.39%
|
$1,773,780
$102.36 P/Share
|
|
Feb 06
2023
|
Julie Cooke Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
1,215
-3.61%
|
$126,360
$104.88 P/Share
|
|
Feb 06
2023
|
Eiry Roberts Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,121
-3.96%
|
$117,705
$105.8 P/Share
|
|
Feb 06
2023
|
Malcolm Lloyd Smith Chief Integration Officer |
SELL
Open market or private sale
|
Direct |
801
-2.66%
|
$84,105
$105.82 P/Share
|
|
Feb 06
2023
|
Darin Lippoldt Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
1,041
-3.22%
|
$109,305
$105.8 P/Share
|
|
Feb 06
2023
|
Kyle Gano Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
1,600
-1.38%
|
$168,000
$105.64 P/Share
|
|
Feb 06
2023
|
Kevin Charles Gorman Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
3,040
-0.65%
|
$319,200
$105.68 P/Share
|
|
Feb 06
2023
|
David W. Boyer Chief Corp. Affairs Officer |
SELL
Open market or private sale
|
Direct |
240
-5.5%
|
$25,200
$105.61 P/Share
|
|
Feb 06
2023
|
Matt Abernethy Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,280
-5.38%
|
$134,400
$105.67 P/Share
|
|
Feb 06
2023
|
Eric Benevich Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
1,280
-6.68%
|
$134,400
$105.63 P/Share
|
|
Jan 31
2023
|
Jude Onyia Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
126
-4.84%
|
$13,608
$108.48 P/Share
|
|
Jan 31
2023
|
Eiry Roberts Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,457
-5.27%
|
$158,813
$109.99 P/Share
|
|
Jan 31
2023
|
Darin Lippoldt Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
1,250
-3.95%
|
$136,250
$109.97 P/Share
|
|
Jan 31
2023
|
Malcolm Lloyd Smith Chief Integration Officer |
SELL
Open market or private sale
|
Direct |
1,666
-5.51%
|
$183,260
$110.02 P/Share
|
|
Jan 31
2023
|
Kyle Gano Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
1,541
-1.35%
|
$167,969
$109.98 P/Share
|
|
Jan 31
2023
|
Kevin Charles Gorman Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
2,707
-0.58%
|
$297,770
$110.08 P/Share
|
|
Jan 31
2023
|
David W. Boyer Chief Corp. Affairs Officer |
SELL
Open market or private sale
|
Direct |
1,104
-22.01%
|
$120,336
$109.92 P/Share
|
|
Jan 31
2023
|
Julie Cooke Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
916
-5.44%
|
$98,928
$108.48 P/Share
|
|
Jan 31
2023
|
Eric Benevich Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
1,207
-6.73%
|
$131,563
$109.95 P/Share
|
|
Jan 31
2023
|
Matt Abernethy Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,283
-5.67%
|
$139,847
$109.98 P/Share
|
|
Jan 06
2023
|
Eric Benevich Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
400
-2.49%
|
$50,000
$125.0 P/Share
|
|
Jan 06
2023
|
Eric Benevich Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
400
+2.43%
|
$17,200
$43.24 P/Share
|
|
Jan 03
2023
|
Stephen A Sherwin Director |
SELL
Open market or private sale
|
Direct |
30,000
-37.45%
|
$3,540,000
$118.86 P/Share
|
|
Jan 03
2023
|
Stephen A Sherwin Director |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+27.25%
|
$360,000
$12.85 P/Share
|
|
Jan 03
2023
|
Richard F Pops Director |
SELL
Open market or private sale
|
Direct |
15,000
-33.7%
|
$1,785,000
$119.2 P/Share
|
|
Jan 03
2023
|
Richard F Pops Director |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+25.21%
|
$180,000
$12.71 P/Share
|
|
Nov 30
2022
|
Eric Benevich Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
50,000
-49.34%
|
$6,250,000
$125.9 P/Share
|
|
Nov 30
2022
|
Eric Benevich Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+32.62%
|
$2,000,000
$40.34 P/Share
|
|
Nov 29
2022
|
Jude Onyia Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
2,331
-49.63%
|
$282,051
$121.9 P/Share
|
|
Nov 10
2022
|
Eric Benevich Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
100
-0.64%
|
$12,500
$125.36 P/Share
|
|
Nov 10
2022
|
Eric Benevich Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
100
+0.63%
|
$4,100
$41.78 P/Share
|
|
Nov 08
2022
|
Julie Cooke Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
5,592
-27.02%
|
$693,408
$124.99 P/Share
|
|
Nov 08
2022
|
Julie Cooke Chief Human Resources Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,592
+21.27%
|
$452,952
$81.05 P/Share
|
|
Nov 08
2022
|
Darin Lippoldt Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
5,082
-14.81%
|
$635,250
$125.04 P/Share
|
|
Nov 08
2022
|
Darin Lippoldt Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,082
+12.9%
|
$218,526
$43.24 P/Share
|
|
Nov 08
2022
|
Eric Benevich Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
24,593
-61.12%
|
$3,074,125
$125.33 P/Share
|
|
Nov 08
2022
|
Eric Benevich Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
24,593
+37.94%
|
$1,008,313
$41.78 P/Share
|
|
Nov 03
2022
|
Darin Lippoldt Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
4,518
-13.39%
|
$564,750
$125.02 P/Share
|
|
Nov 03
2022
|
Darin Lippoldt Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,518
+11.81%
|
$194,274
$43.24 P/Share
|
|
Nov 03
2022
|
Julie Cooke Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
7,264
-32.48%
|
$908,000
$125.0 P/Share
|
|
Nov 03
2022
|
Julie Cooke Chief Human Resources Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,264
+24.52%
|
$588,384
$81.05 P/Share
|
|
Nov 03
2022
|
Eric Benevich Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
8,968
-36.44%
|
$1,121,000
$125.02 P/Share
|
|
Nov 03
2022
|
Eric Benevich Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,968
+26.71%
|
$367,688
$41.78 P/Share
|
|
Nov 02
2022
|
Julie Cooke Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
1,144
-7.04%
|
$141,856
$124.97 P/Share
|
|
Nov 02
2022
|
Julie Cooke Chief Human Resources Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,144
+6.58%
|
$92,664
$81.05 P/Share
|
|
Nov 02
2022
|
Eric Benevich Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
400
-2.49%
|
$50,000
$125.0 P/Share
|
|
Nov 02
2022
|
Eric Benevich Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
400
+2.43%
|
$16,400
$41.78 P/Share
|
|
Nov 02
2022
|
Darin Lippoldt Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
400
-1.35%
|
$50,000
$125.0 P/Share
|